Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

NRS 155 Intro to Pharmacology > Decongestants > Flashcards

Decongestants Flashcards

1
Q

Topical Nasal Decongestants

A

“-zoline”

  • Oxymetazoline
  • Tetrahydrozoline
  • Xylometazoline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Topical Nasal Decongestants: Actions

A

-Decrease the overproduction of secretions by causing local vasoconstriction to the upper respiratory tract (sympathomimetic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Topical Nasal Decongestants: Indications

A

-Relieve the discomfort of nasal congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Topical Nasal Decongestants: Contraindications

A

-Lesion or erosion in the mucous membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Topical Nasal Decongestants: Caution

A
  • Any condition that might be exacerbated by sympathetic activity
  • Pregnancy/lactation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Topical Nasal Decongestants: Adverse effects

A
  • Local stinging and burning
  • Rebound congestion
  • Sympathomimetic effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Topical Nasal Decongestants: Drug-Drug interactions

A
  • Cyclopropane or halothane
  • Other sympathomimetic drugs
  • Sympathetic-blocking drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Topical Nasal Decongestants: Assessment

A
  • History: check for any contraindications or cautions

- Physical: VS, heart and lung sounds, nasal mucous membranes, orientation and reflexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Topical Nasal Decongestants: Nursing diagnoses

A
  • Acute pain

- Deficient knowledge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Topical Nasal Decongestants: Implementation

A
  • Administer the drug properly
  • Non-pharmacologic measures
  • Drug not taken longer than 1 week
  • Further medical eval if persistent symptoms
  • Overdose prevention
  • Safety measures
  • Patient teaching
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Topical Nasal Decongestants: Evaluation

A
  • Patient response
  • Effectiveness of teaching plan
  • Effectiveness of other measures to relieve symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Oral Decongestants

A

-Pseudoepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Oral Decongestants: Action

A
  • Shrink the nasal mucous membrane by stimulating the alpha-adrenergic receptors in the nasal mucous membranes
  • Opens nasal passages to facilitate drainage from middle ear
  • Decreases nasal congestion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oral Decongestants: Indications

A

-Promotion of drainage in the sinuses and improving airflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Oral Decongestants: Contraindications

A
  • Pregnancy/lactation

- Any condition that may be exacerbated by the SNS activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Oral Decongestants: Adverse effects

A
  • Rebound congestion

- Sympathetic effects

17
Q

Oral Decongestants: Drug-Drug interactions

A

-OTC products that contain pseudoepinephrine; taking concurrently can cause serious side effects

18
Q

Oral Decongestants: Assessment

A
  • History: check for any contraindications or cautions

- Physical: VS, heart and lung sounds, urinary status, orientation and reflexes

19
Q

Oral Decongestants: Nursing diagnoses

A
  • Acute pain
  • Increased cardiac output
  • Disturbed sensory perception
  • Deficient knowledge
20
Q

Oral Decongestants: Implementation

A
  • Drug not taken longer than 1 week
  • Further medical eval for persistent symptoms
  • Monitor VS to detect adverse effects
  • Overdose prevention
  • Safety measures
  • Patient teaching
21
Q

Oral Decongestants: Evaluation

A
  • Patient response
  • Effectiveness of teaching plan
  • Compliance
22
Q

Topical Nasal Steroid Decongestants

A

“-one” or “-ide”

  • Beclomethasone
  • Fluticasone
  • Triamcinolone
  • Budesonide
  • Flunisolide
23
Q

Topical Nasal Steroid Decongestants: Action

A
  • Relieve inflammation

- exact MOA is unknown

24
Q

Topical Nasal Steroid Decongestants: Indications

A
  • Seasonal allergic rhinitis

- Inflammation after the removal of nasal polyps

25
Q

Topical Nasal Steroid Decongestants: Contraindications

A

-Acute infection

26
Q

Topical Nasal Steroid Decongestants: Cautions

A
  • Active infection
  • Avoid exposure to airbourne infections
  • Pregnancy/lactation
27
Q

Topical Nasal Steroid Decongestants: Adverse effects

A
  • Local burning, irritation, stinging, dryness of the mucosa, and headache
  • Suppression of healing can occur in a patient who has had nasal surgery or trauma
28
Q

Topical Nasal Steroid Decongestants: Assessment

A
  • History: check for contraindications

- Physical: nasal mucosa, lung sounds, temperature

29
Q

Topical Nasal Steroid Decongestants: Nursing diagnosis

A
  • Acute pain
  • Risk for injury
  • Deficient knowledge
30
Q

Topical Nasal Steroid Decongestants: Implementation

A
  • How to administer properly
  • Generally not absorbed systemically
  • Takes 1-3 weeks to see effect/results
  • Monitor for acute infection
  • Avoid areas where airbourne infection is present
  • Patient education
31
Q

Topical Nasal Steroid Decongestants: Evaluation

A
  • Response to drug
  • Effectiveness of teaching plan
  • Compliance

NRS 155 Intro to Pharmacology (107 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions